Swedish Orphan Biovitrum AB (publ) Website

Swedish Orphan Biovitrum AB (publ)

OM-SOBI

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

14,248

15,261

15,529

18,790

22,123

23,710

Total Revenues % Chg.

55.9%

7.1%

1.8%

21%

17.7%

18%

Cost of Goods Sold, Total

3,319

3,225

3,484

4,413

4,952

5,289

Gross Profit

10,929

12,036

12,045

14,377

17,171

18,421

Selling General & Admin Expenses, Total

4,807

5,981

6,294

7,637

9,773

10,609

R&D Expenses

1,448

1,594

1,987

2,252

2,743

3,257

Other Operating Expenses

-23

-2

-30

-32

-9

-72

Other Operating Expenses, Total

6,232

7,573

8,251

9,857

12,507

13,794

Operating Income

4,697

4,463

3,794

4,520

4,664

4,627

Interest Expense, Total

-241

-454

-419

-458

-1,111

-1,471

Interest And Investment Income

5

1

—

5

27

27

Net Interest Expenses

-236

-453

-419

-453

-1,084

-1,444

Currency Exchange Gains (Loss)

-38

-157

18

-44

-91

-91

Other Non Operating Income (Expenses)

-20

-33

-35

-27

-49

-47

EBT, Excl. Unusual Items

4,403

3,820

3,358

3,996

3,440

3,045

Restructuring Charges

—

—

—

—

-18

—

—

-363

-34

-66

Merger & Related Restructuring Charges

—

—

—

—

—

-110

—

—

—

—

-47

Impairment of Goodwill

—

—

—

—

—

—

—

—

—

—

Gain (Loss) On Sale Of Assets

—

—

—

34

-2

-56

—

-1

-1

Asset Writedown

—

—

—

-63

—

-7

—

-65

-65

Other Unusual Items

—

—

—

—

—

399

—

-312

-385

-254

EBT, Incl. Unusual Items

4,246

4,217

3,295

3,321

2,955

2,612

Income Tax Expense

942

972

616

683

546

467

Earnings From Continuing Operations

3,304

3,245

2,679

2,638

2,409

2,145

Net Income

3,304

3,245

2,679

2,638

2,409

2,145

Net Income to Common Incl Extra Items

3,304

3,245

2,679

2,638

2,409

2,145

Net Income to Common Excl. Extra Items

3,304

3,245

2,679

2,638

2,409

2,145

Total Shares Outstanding

294.3

294.9

295.2

296

339.8

342.5

Weighted Avg. Shares Outstanding

292.6

294.7

295.1

295.6

322.7

337.6

Weighted Avg. Shares Outstanding Dil

294.5

297.6

296.8

298.4

326

341.3

EPS

11.3

11

9.1

8.9

7.5

6.4

EPS Diluted

11.2

10.9

9

8.8

7.4

6.3

EBITDA

6,077

6,319

5,604

6,593

7,548

8,034

Effective Tax Rate

22.2%

23%

18.7%

20.6%

18.5%

17.9%